| Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice MA Collins, F Bednar, Y Zhang, JC Brisset, S Galbán, CJ Galbán, ... The Journal of clinical investigation 122 (2), 639-653, 2012 | 877 | 2012 |
| Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer CJ Halbrook, C Pontious, I Kovalenko, L Lapienyte, S Dreyer, HJ Lee, ... Cell metabolism 29 (6), 1390-1399. e6, 2019 | 392 | 2019 |
| Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer Y Zhang, A Velez-Delgado, E Mathew, D Li, FM Mendez, K Flannagan, ... Gut 66 (1), 124-136, 2017 | 351 | 2017 |
| Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis Y Zhang, J Lazarus, NG Steele, W Yan, HJ Lee, ZC Nwosu, CJ Halbrook, ... Cancer discovery 10 (3), 422-439, 2020 | 334 | 2020 |
| Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance Y Zhang, W Yan, MA Collins, F Bednar, S Rakshit, BR Zetter, BZ Stanger, ... Cancer research 73 (20), 6359-6374, 2013 | 287 | 2013 |
| Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer NG Steele, G Biffi, SB Kemp, Y Zhang, D Drouillard, LJ Syu, Y Hao, ... Clinical Cancer Research 27 (7), 2023-2037, 2021 | 226 | 2021 |
| Metastatic pancreatic cancer is dependent on oncogenic Kras in mice MA Collins, JC Brisset, Y Zhang, F Bednar, J Pierre, KA Heist, CJ Galbán, ... PloS one 7 (12), e49707, 2012 | 215 | 2012 |
| Canonical wnt signaling is required for pancreatic carcinogenesis Y Zhang, JP Morris IV, W Yan, HK Schofield, A Gurney, DM Simeone, ... Cancer research 73 (15), 4909-4922, 2013 | 214 | 2013 |
| Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation CH Shen, P Yuan, R Perez-Lorenzo, Y Zhang, SX Lee, Y Ou, JM Asara, ... Molecular cell 52 (2), 161-172, 2013 | 145 | 2013 |
| Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma SH Kim, M Li, S Trousil, Y Zhang, MP di Magliano, KD Swanson, B Zheng Journal of Investigative Dermatology 137 (8), 1740-1748, 2017 | 144 | 2017 |
| Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation LD Mills, Y Zhang, RJ Marler, M Herreros-Villanueva, L Zhang, LL Almada, ... Journal of Biological Chemistry 288 (17), 11786-11794, 2013 | 131 | 2013 |
| Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-κB–mediated production of CXCL1 SB Kemp, ES Carpenter, NG Steele, KL Donahue, ZC Nwosu, A Pacheco, ... Cancer research 81 (16), 4305-4318, 2021 | 129 | 2021 |
| CD44 regulates pancreatic cancer invasion through MT1-MMP W Jiang, Y Zhang, KT Kane, MA Collins, DM Simeone, MP di Magliano, ... Molecular Cancer Research 13 (1), 9-15, 2015 | 108 | 2015 |
| Dosage-dependent regulation of pancreatic cancer growth and angiogenesis by hedgehog signaling E Mathew, Y Zhang, AM Holtz, KT Kane, JY Song, BL Allen, ... Cell reports 9 (2), 484-494, 2014 | 108 | 2014 |
| Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth H Zhao, D Teng, L Yang, X Xu, J Chen, T Jiang, AY Feng, Y Zhang, ... Nature Metabolism 4 (12), 1660-1673, 2022 | 106 | 2022 |
| CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice Y Zhang, W Yan, E Mathew, F Bednar, S Wan, MA Collins, RA Evans, ... Cancer immunology research 2 (5), 423-435, 2014 | 102 | 2014 |
| Differential contribution of pancreatic fibroblast subsets to the pancreatic cancer stroma PE Garcia, M Adoumie, EC Kim, Y Zhang, MK Scales, YS El-Tawil, ... Cellular and molecular gastroenterology and hepatology 10 (3), 581-599, 2020 | 91 | 2020 |
| Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages SB Kemp, NG Steele, ES Carpenter, KL Donahue, GG Bushnell, ... Life science alliance 4 (6), 2021 | 89 | 2021 |
| Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice MP Lanfranca, Y Zhang, A Girgis, S Kasselman, J Lazarus, I Kryczek, ... Gastroenterology 158 (5), 1417-1432. e11, 2020 | 80 | 2020 |
| Arginase 1 is a key driver of immune suppression in pancreatic cancer RE Menjivar, ZC Nwosu, W Du, KL Donahue, HS Hong, C Espinoza, ... Elife 12, e80721, 2023 | 78 | 2023 |